EXOC5 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOC6B Human Pre-designed siRNA Set A contains three designed siRNAs for EXOC6B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOC7 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOC7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOC8 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOC8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOG Human Pre-designed siRNA Set A contains three designed siRNAs for EXOG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC1 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC10 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC2 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC3 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC4 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC5 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC6 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC7 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC8 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXOSC9 Human Pre-designed siRNA Set A contains three designed siRNAs for EXOSC9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXPH5 Human Pre-designed siRNA Set A contains three designed siRNAs for EXPH5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Exserohilone ((-)-Exserohilone) is a thiodiketopiperazine derivative that exhibits the inhibition of TNF-α-induced ROS generation and MMP-1 secretion. Exserohilone increases the procollagen type I α1 secretion in human dermal fibroblasts[1].

EXT1 Human Pre-designed siRNA Set A contains three designed siRNAs for EXT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXT2 Human Pre-designed siRNA Set A contains three designed siRNAs for EXT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXTL2 Human Pre-designed siRNA Set A contains three designed siRNAs for EXTL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EXTL3 Human Pre-designed siRNA Set A contains three designed siRNAs for EXTL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EYA1 Human Pre-designed siRNA Set A contains three designed siRNAs for EYA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EYA2 Human Pre-designed siRNA Set A contains three designed siRNAs for EYA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EYA3 Human Pre-designed siRNA Set A contains three designed siRNAs for EYA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EYA4 Human Pre-designed siRNA Set A contains three designed siRNAs for EYA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EYS Human Pre-designed siRNA Set A contains three designed siRNAs for EYS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ezetimibe-d4-1 (Standard) is the analytical standard of Ezetimibe-d4-1. This product is intended for research and analytical applications. Ezetimibe-d4-1 is deuterium labeled Ezetimibe. Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.

EZH1 Human Pre-designed siRNA Set A contains three designed siRNAs for EZH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ezh1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ezh1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

EZH2 Human Pre-designed siRNA Set A contains three designed siRNAs for EZH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ezh2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ezh2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ezh2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ezh2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

EZH2-AF647 is a fluorescent probe derived from UNC2239 that improves receptor TR-FRET properties by using Alexa 647 dye[1].

EZH2-IN-18 (compound 9e) is a potent inhibitor of enhancer of zeste homologue 2 (EZH2WT) with the IC50 of 1.01 nM. EZH2-IN-18 shows inhibition in proliferation and induction in apoptosis in tumor cells[1].

EZH2/HSP90-IN-29 is a dual inhibitor for EZH2 and HSP90, with IC50s of 6.29 nM and 60.1 nM, for EZH2 and HSP90, respectively. EZH2/HSP90-IN-29 increases apoptosis/necrosis-related gene expression, induces cell cycle arrest at M phase and inhibits reactive oxygen species (ROS) catabolism pathway. EZH2/HSP90-IN-29 is able to cross the blood-brain-barrier (BBB)[1].

EZHIP Human Pre-designed siRNA Set A contains three designed siRNAs for EZHIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ezlopitant (CJ-11,974) is a selective, non-peptidic neurokinin-1 (NK-1)-receptor antagonist. Ezlopitant inhibits both acute and delayed emetic reactions induced by Cisplatin (HY-17394) in ferrets via acting on NK1 receptors in the central nervous system. Ezlopitant has the potential for pain, chemotherapy-induced emesis and irritable bowel syndrome research[1][2][3].

EZR Human Pre-designed siRNA Set A contains three designed siRNAs for EZR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

F-Amidine TFA is a Protein arginine deiminase 4 (PAD4) inhibitor. F-Amidine TFA can be used in the study of inflammatory and immune system diseases (such as rheumatoid arthritis)[1].

F10 Human Pre-designed siRNA Set A contains three designed siRNAs for F10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

F11 Human Pre-designed siRNA Set A contains three designed siRNAs for F11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

F11R Human Pre-designed siRNA Set A contains three designed siRNAs for F11R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

F12 Human Pre-designed siRNA Set A contains three designed siRNAs for F12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

F13A1 Human Pre-designed siRNA Set A contains three designed siRNAs for F13A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

F13B Human Pre-designed siRNA Set A contains three designed siRNAs for F13B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

F2 Human Pre-designed siRNA Set A contains three designed siRNAs for F2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.